logo

For the Inventor, By the Inventor

Salt Lake City, UT, United States of America

Myrexis, Inc.


USPTO Granted Patents = 12

% Expired Patents = 66.7



Forward Citations = 15

Loading Chart...
Loading Chart...

50 inventors (with patents filed for the assignee):

goldMedal Mark B Anderson (6 out of 11 patents)

silverMedal Yevgeniya Klimova (3 out of 6 patents)

bronzeMedal Sui Xiong Cai (3 out of 87 patents)

4.  Adam Willardsen (3 out of 3 patents)

5.  Ashok Bajji (2 out of 11 patents)

6.  Rachel M Slade (2 out of 7 patents)

7.  Robert J Halter (2 out of 6 patents)

8.  Warren S Weiner (2 out of 10 patents)

9.  Se-Ho Kim (2 out of 3 patents)

10.  Rajendra Tangallapally (2 out of 3 patents)

11.  Kazuyuki Suzuki (2 out of 2 patents)

12.  Nilantha Sudath Sirisoma (2 out of 7 patents)

13.  Kirill Ostanin (1 out of 8 patents)

14.  Hong Zhang (1 out of 30 patents)

15.  Eric O Freed (1 out of 3 patents)


12 patents:

1. 9505800 - Extended triterpene derivatives (2016-11-29),
2. 8476285 - Purine-core inhibitors of HSP90 and their use in treating cancer (2013-07-02),
3. 8318425 - Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein (2012-11-27),
4. 8309562 - Compounds and therapeutical use thereof (2012-11-13),
5. 8258145 - Method of treating brain cancer (2012-09-04),
6. 8217073 - Pyrrole derivatives as therapeutic compounds (2012-07-10),
7. 8017780 - Therapeutic compounds and uses thereof (2011-09-13),
8. 7989462 - 4-arylamin-or-4-heteroarylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof (2011-08-02),
9. 7943146 - Immunizing compositions comprising HIV-1 proviral constructs with an inactive p6 gag TSG101 UEV binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface (2011-05-17),
10. 7842805 - Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof (2010-11-30),
11. 7816099 - Enzyme assay and use thereof (2010-10-19),
12. 7799768 - [object Object] (2010-09-21),
Myrexis, Inc. is a pharmaceutical company focused on drug discovery and development. Our mission is to improve patient outcomes by advancing innovative therapies. With a strong portfolio of potential treatments and a team of dedicated researchers, we are committed to making a difference in the healthcare industry.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

12 Patents

#116 in Salt Lake City, UT

#299 in Utah

#25,526 in US

#48,090 in the World

Salt Lake City, UT (US)
Salt Lake City, UT, United States of America

Myrexis, Inc.

Forward Citations = 15

50 inventors:

goldMedal Mark B Anderson (6 out of 11 patents)

silverMedal Yevgeniya Klimova (3 out of 6 patents)

bronzeMedal Sui Xiong Cai (3 out of 87 patents)

4.  Adam Willardsen (3 out of 3 patents)

5.  Ashok Bajji (2 out of 11 patents)

Please report any incorrect information to [email protected]
Loading…